1. Home
  2. SOFI vs BIO Comparison

SOFI vs BIO Comparison

Compare SOFI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOFI
  • BIO
  • Stock Information
  • Founded
  • SOFI 2011
  • BIO 1952
  • Country
  • SOFI United States
  • BIO United States
  • Employees
  • SOFI N/A
  • BIO N/A
  • Industry
  • SOFI Diversified Financial Services
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • SOFI Finance
  • BIO Industrials
  • Exchange
  • SOFI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • SOFI 25.4B
  • BIO 7.7B
  • IPO Year
  • SOFI N/A
  • BIO N/A
  • Fundamental
  • Price
  • SOFI $27.14
  • BIO $280.82
  • Analyst Decision
  • SOFI Hold
  • BIO Strong Buy
  • Analyst Count
  • SOFI 16
  • BIO 4
  • Target Price
  • SOFI $18.67
  • BIO $333.50
  • AVG Volume (30 Days)
  • SOFI 68.1M
  • BIO 227.8K
  • Earning Date
  • SOFI 10-28-2025
  • BIO 10-29-2025
  • Dividend Yield
  • SOFI N/A
  • BIO N/A
  • EPS Growth
  • SOFI N/A
  • BIO N/A
  • EPS
  • SOFI 0.49
  • BIO 11.49
  • Revenue
  • SOFI $3,029,346,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • SOFI $31.59
  • BIO $2.12
  • Revenue Next Year
  • SOFI $23.46
  • BIO $2.90
  • P/E Ratio
  • SOFI $55.43
  • BIO $24.56
  • Revenue Growth
  • SOFI 29.27
  • BIO N/A
  • 52 Week Low
  • SOFI $7.57
  • BIO $211.43
  • 52 Week High
  • SOFI $27.88
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • SOFI 64.68
  • BIO 48.64
  • Support Level
  • SOFI $25.30
  • BIO $277.40
  • Resistance Level
  • SOFI $27.88
  • BIO $298.00
  • Average True Range (ATR)
  • SOFI 1.18
  • BIO 7.85
  • MACD
  • SOFI 0.05
  • BIO -2.53
  • Stochastic Oscillator
  • SOFI 82.30
  • BIO 17.78

About SOFI SoFi Technologies Inc.

SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: